LYMA Achieves Significant Revenue Growth in 2025 with $48 Million as U.S. Expansion Takes Off

LYMA Achieves Significant Revenue Growth in 2025

LYMA, a luxury regenerative MedTech firm, disclosed its financial performance for the year ending December 31, 2025, revealing that it garnered revenue of $48 million and an EBITDA of $7 million. This impressive growth is largely attributed to the successful expansion into the U.S. market.

The brand's strategic shift towards the U.S. began in earnest following the launch of its flagship product, the LYMA PRO, in April 2025. As consumer demand for scientifically-backed regenerative skincare surged, the U.S. market now accounts for over 70% of LYMA's global sales—highlighting its importance as a key driver of growth.

In the lead-up to the LYMA PRO launch on April 15, anticipation was palpable, with over 16,000 individuals joining the waitlist—translating to a staggering $100 million demand for this innovative device, which retails for approximately $6,000. Initial sales surpassed expectations, boasting a 130% increase in direct-to-consumer sales within the first six months of its launch, further building on the success of its prior European launch where the product sold out twice.

LYMA also established significant retail partnerships with prominent entities such as Revolve, FWRD, Goop, and Dermstore, enhancing its nationwide accessibility across the U.S. This expansion was further endorsed by notable public figures such as Martha Stewart and Sabrina Carpenter, both of whom praised the LYMA Laser in their social media engagements.

Industry experts have acknowledged LYMA’s innovation and quality, with endorsements from beauty and wellness authorities such as Bobbi Brown, Miranda Kerr, Joanna Czech, and many others. The recognition extends across major beauty, technology, and wellness awards, cementing LYMA Laser PRO’s reputation as a leading device in the regenerative skin treatment market.

Lucy Goff, LYMA’s founder and CEO, remarked, "2025 was a transformative year for LYMA as we solidified our position in the U.S. market and demonstrated the global appetite for truly innovative regenerative technology. Our achievements reflect our commitment to delivering clinically-proven results through cutting-edge science, resonating strongly with American consumers who seek both efficacy and luxury."

The brand is anchored in a growth strategy that prioritizes scientific credibility while maintaining its premium position in the luxury wellness sector. LYMA's performance in 2025 sets the stage for continued expansion planned for 2026, focusing on both U.S. and UK markets while eyeing further penetration into regions like Australia and the UAE.

Looking ahead, LYMA anticipates further product innovations and a deeper market presence. Goff expressed gratitude towards the dedicated LYMA team for their efforts in bringing this pioneering product to market, stating, "We are incredibly excited to continue expanding in the U.S. and other key regions while launching new products later in 2026."

The LYMA Laser PRO is powered by a 1450mW near-infrared continuous cold laser beam that penetrates up to 10 centimeters into the dermis, providing dual lifting effects on both skin and muscle while ensuring a treatment experience with zero pain, zero damage, and no downtime. Supported by 38 global patents and five peer-reviewed studies, the LYMA Laser PRO exemplifies unparalleled innovation in the beauty technology sector.